Innovator IBD 50 ETF (NYSEARCA:FFTY) Stock Short Interest Jumps 382.4%

Innovator IBD 50 ETF (NYSEARCA:FFTY) was the target of a large increase in short interest in October. As of October 30th, there was short interest totaling 34,755 shares, an increase of 382.4% from the October 15th total of 7,205 shares. Based on an average daily volume of 36,072 shares, the short-interest ratio is presently 1.0 days. Currently, 2.0% of the shares of the company are sold short.

Innovator IBD 50 ETF Stock Up 0.5%

Shares of NYSEARCA FFTY traded up $0.15 during midday trading on Wednesday, reaching $29.36. 22,241 shares of the stock were exchanged, compared to its average volume of 49,700. The firm has a market cap of $51.38 million, a price-to-earnings ratio of 12.03 and a beta of 1.51. The firm has a 50-day simple moving average of $33.97 and a two-hundred day simple moving average of $37.24. Innovator IBD 50 ETF has a twelve month low of $28.62 and a twelve month high of $44.08.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC boosted its stake in shares of Innovator IBD 50 ETF by 11.1% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock worth $3,349,000 after acquiring an additional 6,321 shares in the last quarter. WorthPointe LLC raised its holdings in Innovator IBD 50 ETF by 18.3% in the 2nd quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock worth $1,295,000 after purchasing an additional 3,771 shares during the period. Kraematon Investment Advisors Inc. purchased a new position in Innovator IBD 50 ETF during the second quarter worth approximately $1,021,000. Royal Bank of Canada boosted its position in Innovator IBD 50 ETF by 3,222.5% during the first quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock worth $611,000 after purchasing an additional 17,724 shares in the last quarter. Finally, Guardian Wealth Advisors LLC NC purchased a new position in Innovator IBD 50 ETF during the second quarter worth approximately $507,000.

About Innovator IBD 50 ETF

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.